Main

Interest and investment in brain science have expanded rapidly in recent decades, rewarding us with exciting discoveries about how nervous systems orchestrate their command over complex adaptive behaviour. Progress is slowed, however, by the fact that many subdomains within neuroscience are fundamentally siloed from one another. There are understandable reasons for this: neuroscience research is conducted in diverse organisms, from humans to rodents to invertebrates; on scales ranging from nanometres (for example, single molecules) to metres (for example, socially interacting humans); using measurement techniques that range from detecting gene expression in single cells to recording electrical activity in groups of neurons and observing complex behaviour (for example, human speech).

This wide range of approaches raises conceptual and empirical barriers that make it inherently difficult to integrate insights or advances across subfields. Yet, ultimately, we will need to bridge across the domains of neuroscience to fully understand how the brain works, as well as to identify and treat its many distinct disorders and syndromes. Without these links, we are tacitly accepting our inability to translate insights from one field (for example, circuit mechanisms for synaptic plasticity following brain stimulation1,2) into another (for example, understanding how and where to stimulate the brain of an individual with a particular disorder in order to confer maximal clinical benefit3).

In this Perspective, we suggest that the technique of fMRI is well-placed to act as an integrative bridge to connect between different subfields of neuroscience (Fig. 1). fMRI has a number of enviable features, such as non-invasive access to both spatial and temporal information at the whole-brain level4, the ability to interrogate human-level cognitive, emotional and motoric capacities5 as well as to acquire commensurate data across species, and a strong grounding in open science practices that are driving heightened validity and reproducibility6,7. Along with these strengths, fMRI also has notable weaknesses, including the fact that the blood oxygen level-dependent (BOLD) signal is an indirect measure of neural activity8. Crucially, these limitations align with prominent strengths of techniques used in other fields, such as the ability to causally drive neural dynamics in ways that reduce ambiguity about the source of signals being measured8. If the unique strengths of fMRI can be leveraged while finding ways to compensate for its weaknesses, network science shows that better integration across a network (that is, increasing the density or strength of connector hubs9,10,11) will help to catalyse robust progress in the field of neuroscience in general.

Fig. 1: fMRI as an integrative catalyst to dissolve modular boundaries in the existing neuroscience network.
figure 1

a, At present, most subdomains in neuroscience are highly insular, with few studies linking across subdomains; a co-citation network of papers published in neuroscience would appear topologically segregated. We foresee an opportunity for fMRI studies to help dissolve these subdomain boundaries, which would integrate the field of neuroscience in ways that will catalyse the formation of new subfields and novel insights into how the brain works. Note that the networks depicted in this figure are entirely conceptual. b, Illustrative example of how, by combining studies in each subdomain with fMRI, a richer perspective can emerge linking across scales and species. c, The benefit of integrating across subfields is that there will be stronger links between precise neural mechanisms and idiosyncratic clinical problems, which will be enriched with computational and cognitive depth (and may also be important targets of inquiry in their own right).

Strengths and weaknesses of fMRI

Unlike structural MRI, which provides detailed anatomical images of the brain, fMRI detects changes in blood flow dynamics that occur while the brain is active12. The most common contrast mechanism, known as the BOLD signal, is based on the principle that there is an increased delivery of oxygenated blood supply to regions of heightened neuronal activity that can be detected using MRI. fMRI is very safe in that it is non-invasive and does not require the use of ionizing radiation. Although fMRI is perhaps most strongly associated with cognitive neuroscience—indeed, one of its core strengths is to provide a window into brain function as people perform specific tasks involving, for example, perception, memory and decision making—its applications are not limited to the cognitive domain. It has also made key contributions to systems, computational and clinical neuroscience, as discussed below.

One key feature of fMRI that makes it well-positioned to serve as a bridge across subfields is that it can be performed in humans as well as all mammalian model systems (for example, rodents and non-human primates), yielding commensurate data that open a direct translational route between species. Another major advantage is its whole-brain access: it can acquire a full three-dimensional brain volume at each readout, with reasonable temporal resolution (on the order of 1 Hz or faster; Box 1 and Fig. 2) and with the highest spatial resolution of any non-invasive imaging technique (on the order of 1 mm or less; Box 1). Although more invasive techniques are preferable for most applications in model systems, even the state of the art in these techniques cannot yet match this whole-brain, simultaneous, depth-agnostic feature of fMRI—for example, in mice, wide-field calcium imaging is typically limited to relatively superficial subsets of the cortical surface, with no ability to simultaneously image subcortical structures. Furthermore, the same safe and non-invasive nature that makes fMRI suitable for humans also makes it more suitable for certain applications in model systems, such as long-term longitudinal designs. Whereas more invasive techniques, such as direct electrophysiological recordings and/or calcium imaging, suffer from problems with localizing the same neurons or neuronal populations across sessions, or even with repeated acquisitions damaging the health of the tissue, fMRI makes it safe and easy to acquire an arbitrary number of repeated measures in the same subject (whether human or animal) and accurately cross-register these measurements with one another. Thus, although fMRI requires substantial technical expertise to acquire and analyse the data, it provides unique benefits that are difficult to obtain with other imaging techniques.

Fig. 2: Benefits and challenges associated with fMRI.
figure 2

Benefits include non-invasive access to the whole brain, with both spatial and temporal information as well as access to a wide range of cognitive functions in awake human participants. Challenges include the indirect nature of the BOLD response, its sluggish temporal nature, regional variations in the strength and nature of the BOLD signal, its susceptibility to various forms of noise (such as head motion and physiological artefacts), as well as the fact that cross-species comparisons can be challenging owing to the typical need for anaesthesia in animal studies. fMRI is also well suited to within-subject designs, but is also expensive and technically challenging (not shown).

Other imaging approaches used in humans offer complementary strengths to those of fMRI; however, each of these has its own weaknesses that we argue make it less suitable to act as an interdisciplinary bridge. Electroencephalography (EEG) provides a more direct measure of electrical activity with millisecond temporal resolution, but the spatial resolution is poor and largely limited to the cortical surface. This impairs our ability to draw links with systems neuroscience, since many key structures are small and/or subcortical (for example, the hippocampus). Collecting surface EEG in small animals is empirically challenging, making it a poor choice for achieving correspondence in cross-species measurements. Magnetoencephalograhy (MEG) provides excellent temporal resolution and spatial resolution that is better than EEG (though still poor in comparison to fMRI). However, MEG requires specialized equipment that is less widely available than MRI machines, and is also difficult or impossible to perform in most smaller model organisms. Positron emission tomography (PET) offers direct links to molecular and cellular neuroscience, but both the temporal and spatial resolution are substantially poorer than fMRI and it is invasive, prohibitively expensive and limited in its availability, making it challenging to scale. It is also inappropriate for some populations (for example, children or pregnant women) owing to exposure to ionizing radiation. Intracranial EEG, in which electrodes are placed directly on or inside neural tissue, comes closest to a ‘gold standard’ for measuring brain activity, but its availability in humans is extremely limited (to neurosurgical patients). Furthermore, it does not offer whole-brain coverage, and electrode placement is determined by clinical rather than research goals.

Despite its strengths over other techniques available in humans, fMRI has several weaknesses worth noting (Fig. 2). First, the BOLD signal is an indirect probe of neuronal activity, tracking instead a complex relationship between spiking activity, local field potentials, glial cell function and vascular smooth muscle cells13,14,15,16. These complex relationships can make it challenging to infer the likely neuronal correlates of localized BOLD changes, particularly as the mechanisms supporting the BOLD response can vary across regions. The BOLD response is also relatively slow, and the spatial resolution of the neurovasculature can also make it difficult to resolve small structures, as well as distinct cell types or sub-cellular processes. Finally, cross-species comparisons can be challenging owing to the fact that animals typically require anaesthesia to undergo MRI scanning.

Despite these limitations, there is reason to be optimistic, as novel imaging sequences are continuing to improve spatial signal to noise17. Furthermore, even invasive imaging techniques considered to capture neuronal activity more directly cannot fully overcome these complex transfer functions: for example, wide-field calcium imaging, arguably fMRI’s main competitor technique for invasive studies in animal models, also requires specialized deconvolution algorithms to separate signal from background18 and link the recovered signal back to the inferred spike-driven events that give rise to it, and just like with the BOLD signal, the choice of algorithm can substantially impact results19. The second main weakness of fMRI is its relatively poor temporal resolution compared to electrophysiological imaging techniques (that is, EEG and MEG). However, especially for cross-species applications, we believe that accurate spatial localization should be prioritized over temporal resolution: when comparing how specific circuits give rise to behaviour across species, the more fundamental task is to establish correspondence in space, to ensure that the signals are coming from the same or homologous regions; only then can the relative timing of events be meaningfully interpreted. Finally, although MRI-based methods are among the safest imaging techniques, they are expensive and can be still inappropriate for some populations, such as those with certain medical implants or who cannot lay prone in the scanner for sufficient periods of time. However, these constraints exclude a much smaller percentage of the population than the constraints of more invasive techniques (for example, PET or intracranial EEG). Therefore, given this landscape, and despite its inherent limitations, we believe that fMRI is the strongest candidate for integrating across subfields of neuroscience.

fMRI in systems neuroscience

There is a historic divide between microscopic, neuronal-level and macroscopic, whole-brain studies in neuroscience20,21. At the small scale, precision is retained over individual elements, but how these microscopic details factor into the coherent whole is often overlooked. By contrast, at the whole-brain level, we gain an appreciation for the low-dimensional constraints imposed on a nervous system embedded within a corporeal body and constrained environment, but trade-off this clarity for an incognizance regarding the precise cellular-level composition of the signals that we track. Discovering the identity of the transfer functions that interconnect these different scales of analysis is a crucial missing piece for the ability to understand how the brain works.

Although there is ongoing debate regarding precisely whether pre- or post-synaptic activity in individual neurons13,16,22,23 or their interactions with astrocytes24 are responsible for the BOLD signal tracked with fMRI (Box 1), there remains little doubt regarding the fact that there is tremendous spatial and temporal organization in BOLD signals recorded across the brain. For instance, tracking simple patterns of zero-lagged correlation between coarsely mapped spatial locations distributed across the brain identifies a set of robust groupings (often referred to as ‘large-scale networks’) that are stable across sessions, individuals and different MRI scanners25,26, but also reconfigure as a function of task performance27, arousal28, learning29, across development30 and as a function of a range of disease processes31. Tremendous recent progress has been made in systematically characterizing these patterns, which have been shown to contain robust low-dimensional structure32, while also covarying with recordings from other neuroimaging modalities, such as the intrinsic time-scale in magnetoencephalography data33, the approximate myelin content from structural imaging data34,35 and the differential expression of a wide range of distinct genes based on postmortem studies36,37,38. This suggests a promising link between the recordings made at the whole-brain level and the microscopic elements that comprise the brain, but as yet there are no effective means for translating between these different scales.

Integrating across scales is a difficult problem for a variety of reasons: recording techniques often trade-off micro-level precision for macro-scale coverage, and few techniques are capable of simultaneously resolving signals at multiple unique scales. This is problematic, as the scales at which microscopic-level neuroscience are conducted are orders of magnitude smaller than those that can currently be detected with even the most powerful high-field fMRI techniques. This gap is of course becoming ever smaller with the advent of improved technologies that map thousands of populations of neurons simultaneously in awake animals, typically using invasive calcium sensors39. However, an important issue remains: there are no currently accessible technologies that can map these microscale dynamics at the resolution of the whole brain, and especially without doing so invasively. However, although whole-brain calcium imaging in mammalian model organisms or any scale of calcium imaging in humans are not yet possible, it is possible to record whole-brain fMRI in humans and other mammal models. In addition, recent advances have made it possible to scan animals without the need for anaesthesia40, offering exciting opportunities to compare and contrast whole-brain imaging signatures of behaviour across species. Thus, a profitable middle-ground could therefore be to use fMRI as a translator between scales, particularly given recent advances in layer-resolved fMRI17 and fast fMRI41 (Box 1).

The ability to state causal hypotheses about circuit-level function in the nervous system that then make testable predictions about macroscopic patterns recorded at the whole-brain scale in humans is crucial for the advancement of the field. Importantly, simultaneously tracking fMRI with microscopic measures of neural activity is not enough—the notoriously difficult problems of learning the transfer functions between signals must also be solved14, while also taking seriously important differences in neural circuitry across species42,43. There are several recent examples of work in this space that provide hope for the future. By combining causal optogenetic manipulation of precise cellular populations in the brain with recordings of whole-brain BOLD signal in lightly anaesthetized rodents, researchers have been able to link the causal perturbation of neural populations to the large-scale network signatures that can be recorded at the whole-brain level44,45. Analogous approaches that electrically perturb the brain of humans with implanted electrodes during fMRI recording provide similar causal access to the brain, albeit at a coarser spatial resolution than those provided by optogenetic methods46,47. Optogenetic fMRI techniques have also been combined with gene-expression maps to shed light onto how neuromodulators may regulate aspects of human behaviour via large-scale receptor networks48. Other approaches have combined BOLD with other imaging modalities, such as calcium recordings49 or electrophysiology50,51, to determine whether the patterns inherent within each technique coincide or differ. Early progress appears promising, although there are many idiosyncratic details inherent to neural circuitry, including sensitivity to arousal states52,53 and neurochemical alterations across rostrocaudal hierarchies in the brain54,55, that remain to be effectively dealt with before the field can deliver upon the pressing need for a translational tool that enables mapping across the vastly different spatial scales required to link these different methods.

fMRI in cognitive neuroscience

Once more robust links between the microcircuitry of the brain and the macroscopic measures that we record from fMRI have been created, that microcircuitry can be linked to the emergent capacities of nervous systems by taking advantage of what has been a longstanding advantage of whole-brain imaging in humans: the capacity to shed light on the internal cognitive, emotional and motivational processes that give rise to human behaviour and thought. Developments in signal acquisition and novel analytic strategies (Box 1) have enabled substantial and meaningful changes in the role of fMRI in this process.

On the data acquisition front, by acquiring depth-dependent or ‘layer-specific’ measurements using high-field fMRI, we can characterize directional circuits via the fact that top-down (feedback) and bottom-up (feed-forward) activity have distinct depth profiles across the cortical column. Critically, these layer-specific signatures of activity in humans can also be compared to observations using depth-dependent probes in animal models17,56,57,58, thus affording opportunities to test longstanding theories of predictive coding in human participants59. Whereas early layer-specific fMRI work sought to validate these methods by extending well-established findings from animal model systems into humans, more recent studies have begun to make novel discoveries that would be difficult or impossible to test in animal models. These studies are now informing theories of cognition in their own right. For example, theoretical studies comparing perception (actually experiencing an external stimulus) with mental imagery (calling a stimulus to mind or imagining a behaviour without performing it) suggest precise differences in the cortical circuits responsible for these two processes60; layer-specific fMRI studies are beginning to tease these phenomena apart in terms of their top-down versus bottom-up profiles61,62. Findings from layer-specific fMRI are also informing theories of attention63,64,65, the effects of which can markedly change both brain activity and behaviour for otherwise identical stimuli. For example, one study64 was able to dissociate multisensory interactions from top-down attention into two distinct depth-dependent profiles, suggesting that these are two (at least partially) separable mechanisms by which the brain regulates and prioritizes information flow.

The combination of incisive experimental paradigms with nuanced approaches to data analysis has also led to rapid progress in cognitive neuroscience. For example, careful task designs combined with model-based analysis strategies have revealed that the brain uses a grid-like code to navigate both spatial and nonspatial (that is, conceptual) relationships66,67 and to organize episodic memories68, akin to the grid cells that have been observed during spatial navigation in non-human animals. Building on longstanding work in the field of reinforcement learning69, recent studies have used fMRI to distinguish between possible models of how the brain computes subjective value70, to delineate mechanisms for learning from direct experience versus social observation71, and to dissociate the effects of errors of action selection versus execution on learning72. Of note, these studies depart somewhat from earlier model-based approaches, which fit models to behavioural data first to choose the winning model, then search for the neural correlates of the relevant cognitive operations73. Rather, in these cases, the models under study make similar predictions about ultimate behaviour, meaning that it would it be difficult or impossible to adjudicate between them using behaviour alone. Instead, in these studies, models are fit directly to the neural data to search for evidence of the hypothesized latent operations at intermediate steps in the cognitive process. Although it is possible that the same conclusions could have been reached using EEG, MEG, or another technique, it is unlikely that they could have been reached with the same spatial specificity of fMRI, given that many of the structures in question were relatively deep (for example, striatum, thalamus and medial prefrontal cortex). This spatial specificity in humans is important for links across species, and should be especially prioritized in the fields of reward learning and decision making, where there are exciting opportunities to translate similar tasks and circuits between humans and animal models. These examples thus underscore a critical role for fMRI in deepening our understanding of the mechanisms of cognition in ways that can also meaningfully interface with other subfields of neuroscience.

With this new wave of studies fuelled by methodological advances, the capacity for fMRI to help integrate cognitive neuroscience with the domains of systems, computational and clinical neuroscience offers exciting opportunities for advancement. One example of where these efforts are already bearing fruit is studies of the medial temporal lobe (particularly the hippocampus; Fig. 1b) and cross-species phenomena such as replay and reactivation, processes by which humans consolidate memories and learn new information74,75. These processes typically occur ‘offline’ (while individuals are not focused on a particular task, and often without explicit awareness) and are therefore not accessible to behavioural probes, and also critically involve deep brain structures in the medial temporal lobe, such that fMRI has been a critical tool for characterizing these phenomena in humans. These phenomena are thus a prime example of how fMRI is well-positioned to link across scales, which requires high spatial precision which can be achieved using both non-invasive fMRI (in humans or animal models) and invasive recordings (in animal models76 or occasionally, humans undergoing intracranial recordings).

To further interface with systems neuroscience, future work could leverage these clear links across species and scales to refine our understanding of the general transfer function(s) that map invasive recordings in animal models to fMRI in humans; these function(s) could in turn be applied to the measurements collected in other experiments to make more precise translational predictions and/or more precisely evaluate the extent to which cross-species findings converge or diverge, despite the substantial differences in recording techniques. On the computational side, a great deal is understood regarding the computational nature of hippocampal circuitry77,78, and these algorithmic features can be refined through the design of sophisticated cognitive tasks that would be difficult to perform in animals67,79. Finally, many clinical disorders, such as Alzheimer’s disease80 and epilepsy81, depend critically on pathology within the medial temporal lobe, suggesting that advances in our mapping of these disorders using functional imaging82 will be reciprocally informed by links to clinical neuroscience and data from patient populations (Fig. 1b). Importantly, this is merely one example of a broader capacity inherent within functional neuroimaging to advance our understanding of how brain systems support cognitive functions in a way that meaningfully intersects with systems, computational and clinical neuroscience (Fig. 1c).

fMRI in computational neuroscience

Armed with functional neuroimaging access to cognitive processes, neuroscientists are faced with the novel challenge of how to make sense of the complex patterns inherent within functional neuroimaging data. Although the trade-off between functional localization and integration has long been appreciated83,84, functional neuroimaging was for many years primarily focussed on ‘brain mapping’—that is, developing links between particular regions or networks of the brain and specific mental functions. This approach led to major advances in our appreciation of brain function—for instance, in the characterization of distributed networks that are engaged consistently across different tasks85 and are predictive of cognitive capacities86. However, the approach falls short in explaining precisely how the different specialized regions work together to give rise to higher cognitive functions, such as fluid intelligence and problem-solving87. This is, of course, a difficult problem that requires a ‘birds-eye’ view of the system (that is, precisely the vantage point offered by fMRI); however it is also challenging to discern coherent algorithmic order from a set of relatively heterogeneous studies. What is needed are ways to sift through the complexity of whole-brain imaging to make sense of the principles that link patterns of brain activity to mental functions.

A promising approach to addressing this question has emerged through the use of artificial neural networks. Whereas previous computational approaches to fMRI analysis often used relatively abstract models of a particular computational subcomponent of a task, artificial neural networks have inspired an alternative approach to mapping neural computations to brain activity88,89: namely, by training the connections within a structured network of brain-inspired computational units in such a way that the network can perform tasks in an end-to-end manner (that is, from stimulus to response). These models can now perform as well as (or better) than humans on many complex tasks90. Although it is clear that these network are not accurate re-creations of detailed biological networks—for example, the commonly used back-propagation training algorithm may be quite distinct from the learning rules used by biological neural networks88 and artificial neural networks fail to account for key findings from human psychology—the key issue is that the distributed nature of the networks forces the system to solve the computational problem using some of the same kinds of degrees of freedom available to biological neural networks (that is, as distributed networks of units with varying strengths of connections between them91). To the extent that the brain solves computational problems in a similar way to artificial neural networks, trained networks can be thought of as a type of ‘computational model organism’ that can be interrogated in order to identify the computational components of the model that are most predictive of signals recorded from biological brains, thus providing further insight into the function of the brain.

Perhaps most crucially, the types of tasks performed by human participants can tap into complex, language-based cognitive capacities that are essentially impossible to study using non-human models. When the data from these human experiments is subsequently mapped to computational models, the models can be extended beyond the reaches of the behaviours that can be interrogated in animals, while retaining contact with the many hard-earned facts about the nervous system identified using the tools of systems neuroscience. That is, inspiration can be drawn from computational models that successfully replicate human behaviour to help answer the difficult ‘how’ question (the algorithmic level, in the language of Marr92), while evaluating candidate solutions against measurements from fMRI—and then grounding those results with more precise measurements from systems neuroscience with known links to fMRI—to determine whether a given computational solution has a plausible neural implementation. This iterative process will afford the ability to refine existing cognitive ontologies93,94 using mechanisms and methods that are ideally suited to unpacking the structure of cognition.

To this end, a promising area that requires further development is determining precisely if and how existing artificial neural network architectures map onto the functions of the human brain. For instance, pioneering work showed that hierarchical convolutional neural networks, which combine many layers and filters to mimic dimensionality collapse and expansion95, provide a robust means for modelling key features of the mammalian visual system96,97. Precisely how these models map onto the complexity of the visual system remains an open question98; however, the open release of high-quality datasets designed for just this purpose will no doubt accelerate our progress in this sphere99. Recent work has also demonstrated similar isomorphisms between human brain activity related to language understanding (as measured using invasive electrophysiology) and the autoregressive neural network (‘transformer’) architectures that have become highly successful at many linguistic tasks100.

This approach holds great promise for mapping more abstract, cognitive functions using the same tools—for example, by training recurrent neural networks to perform simulacra of cognitive tasks101,102, after which time the function of the networks can be interrogated using the same methods that used to analyse functional neuroimaging data103. By comparing signatures of neural networks performing cognitive tasks with fMRI patterns from human participants, the similarities and differences in the computational solutions to cognitive challenges can be identified. Conversely, one can also use fMRI to inform the generation of new task-optimized neural network models104. Yet another promising approach has used artificial neural networks to assess the degree to which stimuli are actually diagnostic with respect to specific theoretical debates105 (in this case regarding the role of perirhinal cortex in memory versus perception), leading to resolution of apparent inconsistencies between human and macaque lesion results106. In short, there are of course crucial ways in which human brains differ from artificial neural networks88,107,108,109, yet the similarities and the differences between the two provide a number of avenues to potentially inform our understanding of how the brain gives rise to cognition.

fMRI in clinical neuroscience

At the advent of fMRI, many believed that its ultimate promise would be to develop tools for clinical and other real-world settings. Currently, fMRI is used for pre-surgical mapping to ensure that key brain regions are not damaged during resections110, and more recently, to guide targeted placement of electrodes for deep brain stimulation111 as well as non-invasive stimulation techniques such as transcranial magnetic stimulation112. However, these applications remain relatively niche, and many agree that the full promise of fMRI for diagnosing and/or treating psychiatric and neurological illnesses has not been borne out113. One major challenge that has prevented fMRI from making meaningful clinical inroads is that while nearly all the discoveries discussed above were based on aggregating data from multiple individuals, to develop tools with real-world value, we need to identify biomarkers for neurological or psychiatric illnesses that are sensitive and specific at the individual ‘n of 1’ level, which is a fundamentally difficult statistical challenge.

The dream of fMRI-based tools that are suitable for widespread, routine clinical use may be far from reality, as proposed imaging-based biomarkers have turned out to be unreliable114 or too weak to support robust inference at the individual level115, perhaps because they have been built on insufficient data116. This is not to say that fMRI in its current state cannot make meaningful contributions to clinical neuroscience; rather, we suggest that a renewed focus on how basic scientific discoveries occurring in systems, cognitive and computational neuroscience can inform clinical neuroscience, and vice versa.

One challenge for n of 1 biomarkers is that behaviour and brain function are marked by considerable variability both within and across individuals. Ultimately, then, understanding links between brain, behaviour, and clinical status will require mapping of the full space of possible values for the measures extracted on a spectrum from health to pathology. Although behavioural work has long recognized within-subject fluctuations in how subjects perform a particular task (for example, trial-to-trial variability), fMRI can reveal the neural basis for why these fluctuations occur—in other words, how endogenous brain states influence if and how incoming sensory information is processed28,117,118,119. Such neural and behavioural fluctuations across a range of different timescales—from seconds to years—have the potential to inform our understanding of symptom trajectories and responses to treatment120. They also highlight a fundamental problem in the logic of most current neuroimaging studies of mental health disorders: By sampling individuals at a single point in time, these studies systematically neglect the temporal variability that is known to occur in many such conditions. Longitudinal designs that relate within-subject brain changes to behavioural changes in the name of prognosis may be a more fruitful avenue for clinical applications of fMRI than single-timepoint diagnostic prediction. Similarly, while rich across-subject variability (that is, individual differences) is well established across many domains (personality, affect, cognitive and motor skills, and so on), understanding the brain basis of these differences can reveal how and why different brains perform the same task or react to the same information differently, and how this might relate to disease or risk of disease121,122,123. Again, even in the absence of n of 1 biomarkers, basic science regarding neural variability can inform clinical practice in other ways, such as by suggesting novel interventions. For example, knowing which features or events within a complex stimulus, such as a film, trigger differential brain responses across individuals might suggest novel targets for cognitive-behavioural therapy.

Another way in which fMRI can inform clinical neuroscience is by contributing to a mechanistic understanding of symptoms. One powerful example is hallucinations, or perceptual experiences in the absence of external stimulation. Hallucinations are a transdiagnostic phenomenon: while auditory (often verbal) hallucinations are a hallmark of schizophrenia, they are also associated with several other conditions and sensory domains (for example, visual hallucinations in Parkinson’s disease). Several theories attempt to explain hallucinations in terms of predictive coding and aberrant weighting of perceptual priors in constructing sensory experience124. Older neuroimaging studies were concerned with identifying loci of activity associated with hallucinations125 to understand the extent to which hallucinations resemble true sensory experiences in their functional neuroanatomy, whereas more recent fMRI studies are leveraging methodological advances to build a more mechanistic understanding of when, how and why hallucinations occur. For example, layer-specific fMRI can provide empirical evidence to constrain predictive coding accounts, helping to adjudicate whether aberrant prediction errors result from impaired top-down or bottom-up signals126, and combining fMRI with computational models of conditioned hallucination tasks can shed light on the neural circuitry underlying latent cognitive processes that give rise to hallucinations127. In addition to having the potential to advance clinical science (for example, by suggesting new targets for therapies), both of these directions also strengthen bridges between clinical and systems, cognitive and computational neuroscience.

While much attention is rightfully focused on how discoveries in basic science can inform clinical problems, there is also a richness of possible reciprocal contributions that fMRI can facilitate from clinical neuroscience back to the basic science modules of systems, cognitive and computational neuroscience. Psychoactive medications offer a way to causally manipulate microscale phenomena—for example, by targeting specific neurotransmitter systems—in humans in an admittedly blunt, yet ethically acceptable way. If it is known from animal models how manipulating these microscale phenomena should affect more macro-scale patterns of brain activity, pharmacological fMRI studies can be used to validate that the same principles apply in humans. With respect to computational neuroscience, to the extent that it is possible to model how mental processes work and how they are instantiated in the brain, it will be possible to test whether disruptions at various levels within those models yield data that match neural and/or behavioural deficits seen in disease. As an example, pharmacological agents that perturb dopaminergic function have been used to confirm the association of fMRI signals in the striatum with dopaminergic reward prediction errors128. This approach is a core principle of the rapidly growing field of computational psychiatry129.

A roadmap for the future of fMRI

This Perspective began by highlighting the relatively segregated nature of the current field of neuroscience (Fig. 1). We then argued that, despite its limitations (Fig. 2), fMRI is a tool that has a number of positive features that allow it to cut across and integrate these relatively isolated sub-disciplines. Through this integration, we envision a future in which fMRI acts as a connector hub9, bringing the pieces of our field back together to rediscover communication between otherwise segregated subfields.

Advances on a number of fronts will accelerate this progression (Fig. 3). Key amongst these is a need for more precise appreciation of how the BOLD response aligns with detailed neuronal recordings at the microscopic scale, which we anticipate will emerge from multimodal image integration. By refining the biophysical understanding that enables translation between different imaging modalities, predictions created in one domain (such as the causal role that a specific cortical cell type has in a particular cognitive task130) and perhaps more complex cognitive contexts that are difficult or impossible to image in non-human species (such as complex social interactions131 or highly abstract, rule-based tasks132) will be able to be tested in other species. We also anticipate a heightened importance of the neuroanatomical characterization of the cellular components of the human brain, specifically so as to ensure that comparisons across species are conducted with high precision; this aim will be greatly facilitated by the ongoing efforts of the BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative Cell Atlas Network. Combining this cellular-level detail with the causal techniques used in non-human model organisms133 as well as BOLD imaging will markedly improve our ability to interpret the measures that we collect non-invasively in human subjects. The complex causal networks identified using these approaches will further augment existing biophysical models that expose the mechanisms underlying higher-level brain functions.

Fig. 3: Potential paths towards a more integrative neuroscience.
figure 3

These paths include (clockwise, from top-left): using biophysical models to link cognition to psychology; combining precise causal perturbation of the brain (for example, with optogenetics) with whole-brain BOLD imaging to improve our understanding of the signals recorded from purely descriptive experiments; open science practices to ensure that results are robust, reproducible and generalizable; dense-sampling approaches that balance individual precision with robust statistical analyses to provide strong conclusions that retain heightened interpretability; recordings across a wide array of cognitive tasks to leverage a key strength of fMRI and mitigate the limitations of approaches in non-human animals; using circuit-level insights to populate biophysical models of the nervous system to refine our understanding of the neural mechanisms of cognitive function; improved recording techniques, such as layer-resolved fMRI and heightened resolution in the subcortex, to augment our appreciation of patterns of whole-brain coordinated activity; and understanding the links between different imaging modalities.

Progress in the field will also be catalysed by continued advances in signal acquisition and paradigm design, particularly those that improve our ability to discern different neuroanatomically relevant signals in the brain during the performance of cognitive tasks. By carefully considering the breadth and scope of cognitive tasks used in fMRI studies in both humans and in animal models, the wide range of our cognitive capacities will be more effectively mapped in both healthy and disease states. To this end, studies designed to robustly track individual differences in whole-brain organization will enable us to combine the power of statistical approaches with the precision afforded by idiosyncratic cognitive and affective capacities. Finally, from a meta-scientific perspective, in recent years the fMRI community has been at the forefront of practices such as data and code sharing and efforts to ensure replicability and generalizability that can serve as a model for other scientific communities (Box 2). This, in turn, can reinforce the integrative role of fMRI as well as help ensure overall scientific progress within and across subfields.

The complex, multi-scale organization of the brain does not lend itself to interrogation from a single vantage point. Overall, we maintain that the next wave of breakthroughs in neuroscience will be catalysed by a pluralistic approach that leverages the benefits of particular empirical tools to bolster the weaknesses of others, with fMRI serving as a key connector hub. In sum, there is a timely opportunity to refine our understanding of how the coordinated activity of the brain shapes the intrinsic processes that generate human behaviour and thought.